Cargando…
MiRNA-125a-5p: a regulator and predictor of gefitinib’s effect on nasopharyngeal carcinoma
BACKGROUND: Nasopharyngeal carcinoma (NPC) is a common malignancy in China and Southeast Asia. Radiotherapy is the major treatment modality for patients with NPC, but does not always achieve fully satisfactory outcomes. Studies have shown that epidermal growth factor receptor (EGFR) is highly expres...
Autores principales: | Liu, Yanyang, Li, Zhixi, Wu, Lu, Wang, Zi, Wang, Xia, Yu, Yang, Zhao, Qian, Luo, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973965/ https://www.ncbi.nlm.nih.gov/pubmed/24602316 http://dx.doi.org/10.1186/1475-2867-14-24 |
Ejemplares similares
-
miR-125b-5p inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma via targeting TXNRD1
por: Hua, Shengni, et al.
Publicado: (2019) -
The oncogenic role of HIF-1α/miR-182-5p/ZFP36L1 signaling pathway in nasopharyngeal carcinoma
por: Wang, Gang, et al.
Publicado: (2021) -
miR-429 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by downregulation of TLN1
por: Wang, Zhihui, et al.
Publicado: (2019) -
miR-324-3p suppresses migration and invasion by targeting WNT2B in nasopharyngeal carcinoma
por: Liu, Chao, et al.
Publicado: (2017) -
MiRNAs in Radiotherapy Resistance of Nasopharyngeal Carcinoma
por: Tian, Yutong, et al.
Publicado: (2020)